Mesenchymal stem cell-derived exosomes as a plausible immunomodulatory therapeutic tool for inflammatory diseases
Frontiers in Cell and Developmental Biology · 10.03.2025 · 13
DOI: 10.3389/fcell.2025.1563427 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 10.03.2025. Verfasst von Muhammad Zubair und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Wujin Hospital Affiliated with Jiangsu University, Changzhou, China. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 276 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs), especially, exosomes are considered to have diverse therapeutic effects for various significant diseases. MSC-derived exosomes (MSCex) offer substantial advantages over MSCs due to their long-term preservation, stability, absence of nuclei and fewer adverse effects such as infusion toxicity, thereby paving the way towards regenerative medicine and cell-free therapeutics. These exosomes harbor several cellular contents such as DNA, RNA, lipids, metabolites, and proteins, facilitating drug delivery and intercellular communication. MSCex have the ability to immunomodulate and trigger the anti-inflammatory process hence, playing a key role in alleviating inflammation and enhancing tissue regeneration. In this review, we addressed the anti-inflammatory effects of MSCex and the underlying immunomodulatory pathways. Moreover, we discussed the recent updates on MSCex in treating specific inflammatory diseases, including arthritis, inflammatory bowel disease, inflammatory eye diseases, and respiratory diseases such as asthma and acute respiratory distress syndrome (ARDS), as well as neurodegenerative and cardiac diseases. Finally, we highlighted the challenges in using MSCex as the successful therapeutic tool and discussed future perspectives.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Wujin Hospital Affiliated with Jiangsu University, Changzhou, China.
- Wujin Institute of Molecular Diagnostics and Precision Cancer Medicine of Jiangsu University, Wujin Hospital Affiliated with Jiangsu University, Changzhou, China.
- Faculty of Applied Health Sciences Technology, Pharos University, Alexandria, Egypt.
- School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China.
- Department of Traditional Chinese Medicine, Wujin Hospital Affiliated with Jiangsu University, Changzhou, China.
- Department of Emergency, Wujin Hospital Affiliated With Jiangsu University, Changzhou, China.
Zitieren
APA
Zubair, M., Abouelnazar, F. A., Iqbal, M. A., Pan, J., Zheng, X., Chen, T., Shen, W., Yin, J., Yan, Y., Liu, P., Mao, F., & Chu, Y. (2025). Mesenchymal stem cell-derived exosomes as a plausible immunomodulatory therapeutic tool for inflammatory diseases. Frontiers in Cell and Developmental Biology, 13. https://doi.org/10.3389/fcell.2025.1563427
Vancouver
Zubair M, Abouelnazar FA, Iqbal MA, Pan J, Zheng X, Chen T, et al. Mesenchymal stem cell-derived exosomes as a plausible immunomodulatory therapeutic tool for inflammatory diseases. Frontiers in Cell and Developmental Biology. 2025;13. doi:10.3389/fcell.2025.1563427
BibTeX
@article{Zubair2025,
author = {Zubair, Muhammad and Abouelnazar, Fatma A and Iqbal, Muhammad Asad and Pan, Jingyun and Zheng, Xuwen and Chen, Tao and Shen, Wenming and Yin, Jinnan and Yan, Yongmin and Liu, Pengjun and Mao, Fei and Chu, Ying},
title = {Mesenchymal stem cell-derived exosomes as a plausible immunomodulatory therapeutic tool for inflammatory diseases},
journal = {Frontiers in Cell and Developmental Biology},
year = {2025},
volume = {13},
doi = {10.3389/fcell.2025.1563427}
}
EUVIMED